Stable Isotopes Product Detail
Home Stable Isotopes CS-T-100058

4-​(6-​Methoxy-​3-​pyridinyl)​-​1-​piperazinecarboxylic Acid-d4 1,​1-​Dimethylethyl Ester

Chemical Properties and Information

Product Code: CS-T-100058 Stable Isotopes
4-​(6-​Methoxy-​3-​pyridinyl)​-​1-​piperazinecarboxylic Acid-d4 1,​1-​Dimethylethyl Ester
API Family
--
Product Code
CS-T-100058

4-​(6-​Methoxy-​3-​pyridinyl)​-​1-​piperazinecarboxylic Acid-d4 1,​1-​Dimethylethyl Ester

Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-100058
CAS No.
--
Molecular Formula
C₁₅H₁₉D₄N₃O₃
Molecular Weight
297.39
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-100058
M.F.
C15H19D4N3O3
M.W.
297.39
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
"4-?(6-?Methoxy-?3-?pyridinyl)?-?1-?piperazinecarboxylic Acid-d4 1,?1-?Dimethylethyl Ester"
References
"Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)"
Synonyms
4-​(6-​Methoxy-​3-​pyridinyl)​-​1-​piperazinecarboxylic Acid-d4 1,​1-​Dimethylethyl Ester
Application Notes
"4-???(6-???Methoxy-???3-???pyridinyl)???-???1-???piperazinecarboxylic Acid-d4 1,???1-???Dimethylethyl Ester is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
Hazard Compound
Refer MSDS for complete information.
Overview
"4-???(6-???Methoxy-???3-???pyridinyl)???-???1-???piperazinecarboxylic Acid-d4 1,???1-???Dimethylethyl Ester is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.